4.4 Review

Arrhythmogenic Cardiomyopathy and Athletes: A Dangerous Relationship

期刊

CURRENT PROBLEMS IN CARDIOLOGY
卷 48, 期 9, 页码 -

出版社

MOSBY-ELSEVIER
DOI: 10.1016/j.cpcardiol.2023.101799

关键词

-

向作者/读者索取更多资源

Arrhythmogenic cardiomyopathy (ACM) is a disease characterized by progressive replacement of myocardium by fibro-adipose material, leading to ventricular arrhythmias and sudden cardiac death. It is more common in males and usually onset in the 2nd to 4th decade of life. ACM is one of the most common causes of sudden cardiac death in young patients, especially athletes. Exercise can worsen right ventricular function in hereditary ACM.
Arrhythmogenic cardiomyopathy (ACM) is a disease characterized by a progressive replacement of myocardium by fibro-adipose material, predispos-ing to ventricular arrhythmias (VA) and sudden car-diac death (SCD). Its prevalence is estimated at 1:2000 to 1:5000, with a higher incidence in males, and clini-cal onset is usually between the 2nd and 4th decade of life. The prevalence of ACM in SCD victims is rela-tively high, making it one of the most common etiolo-gies in young patients with SCD, especially if they are athletes. Cardiac events occur more frequently in indi-viduals with ACM who participate in competitive sports and/or high-intensity training. In effect, exercise activity can worsen RV function in cases of hereditary ACM. Estimating the incidence of SCD caused by ACM in athletes remains challenging, being reported frequency ranging from 3% to 20%. Here, we review the potential implications of exercising on the clinical course of the classical genetic form of ACM, as well as the diagnostic tools, risk stratification, and the differ-ent therapeutic tools available for managing ACM. (Curr Probl Cardiol 2023;48:101799.)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据